Search results
Results from the WOW.Com Content Network
Financials as of September 30, 2023. [update] [1] Cencora, Inc., formerly known as AmerisourceBergen, is an American drug wholesale company and a contract research organization that was formed by the merger of Bergen Brunswig and AmeriSource in 2001. [2]
Let's see if AmerisourceBergen Corporation (ABC) stock is a good choice for value-oriented investors right now, or if investors subscribing to this methodology should look elsewhere for top picks.
AmerisourceBergen (ABC) possesses solid growth attributes, which could help it handily outperform the market. Is AmerisourceBergen (ABC) a Solid Growth Stock? 3 Reasons to Think "Yes" Skip to main ...
AmerisourceBergen's (ABC) fiscal third-quarter results are likely to reflect solid performance at Pharmaceutical Distribution and Other units.
AmerisourceBergen (ABC) is well positioned to outperform the market, as it exhibits above-average growth in financials. AmerisourceBergen (ABC) is an Incredible Growth Stock: 3 Reasons Why Skip to ...
This page was last edited on 31 August 2023, at 09:27 (UTC).; Text is available under the Creative Commons Attribution-ShareAlike License 4.0; additional terms may ...
For premium support please call: 800-290-4726 more ways to reach us
Steven H. Collis (born 1961) is an American businessman, the chairman, president and chief executive officer (CEO) of Cencora, previously known as AmerisourceBergen. Early life. Collis was born in South Africa and attended the University of Witwatersrand, where he earned a Bachelor of Commerce. Collis is Jewish. Career